Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The biologics sector is very dependent on single-use products and containment s...
1. Introduction: Usability Was Always There—MDR Just Started Asking th...
The condition has an estimated prevalence of 25,000 patients in the US and an an...
The approval applies to patients whose disease is metastatic or locally advanced...
Sigachi Industries, a leading global manufacturer of pharmaceutical excipients ...
The government is considering a separate licensing framework for bulk drugs, ac...
Dr. Reddy’s Laboratories announced the launch of Hevaxin, a novel recombinant v...
India’s healthcare and pharmaceutical industries stand at an inflection point. ...
The approval provides a new treatment option for this rare condition, which is l...
The first-in-class, subcutaneously administered hepcidin mimetic peptide, rusfer...
Pharmaceutical firms may no longer have to appear in courts in case of “certain...
When the Central Drugs Standard Control Organization (CDSCO) revised Good Manuf...
Pandorum Technologies, a clinical-stage regenerative medicine company building ...
What inspired you to write The Dual Mandate in B2B, and how is it different fro...
The leadership of Pharmaceuticals Export Promotion Council of India (PHARMEXCIL...
The partnership combines Insilico’s AI drug discovery platforms with Servier’s e...
